|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/4166 | (2006.01) |
| A61K 31/4178 | (2006.01) | ||
| A61K 31/4439 | (2006.01) | ||
| C07D 233/86 | (2006.01) | ||
| C07D 401/04 | (2006.01) |
| (11) | Number of the document | 3412290 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18181743.8 |
| Date of filing the European patent application | 2007-03-27 | |
| (97) | Date of publication of the European application | 2018-12-12 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-03 |
| (46) | Date of publication of the claims translation | 2021-04-26 |
| (30) | Number | Date | Country code |
| 78597806 P | 2006-03-27 | US | |
| 83379006 P | 2006-07-28 | US |
| (72) |
JUNG, Michael E, US
SAWYERS, Charles L, US
OUK, Samedy, US
TRAN, Chris, US
WONGVIPAT, John, US
|
| (73) |
The Regents of the University of California,
1111 Franklin Street, 12th Floor, Oakland, CA 94607,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Androgeno receptorių moduliatorius, skirtas prostatos vėžio bei su androgeno receptoriais susijusių ligų gydymui |
| ANDROGEN RECEPTOR MODULATOR FOR THE TREATMENT OF PROSTATE CANCER AND ANDROGEN RECEPTOR-ASSOCIATED DISEASES |
| Payment date | Validity (years) | Amount | |
| 2025-03-04 | 19 | 347.00 EUR |
| 2026-03-27 |